A citation-based method for searching scientific literature


List of co-cited articles
756 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Ondrej Lisy, Brenda K Huntley, Daniel J McCormick, Paul A Kurlansky, John C Burnett. J Am Coll Cardiol 2008
124
63

Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.
Candace Y W Lee, Horng H Chen, Ondrej Lisy, Suzanne Swan, Courtney Cannon, Hsiao D Lieu, John C Burnett. J Clin Pharmacol 2009
76
44

Effect of nesiritide in patients with acute decompensated heart failure.
C M O'Connor, R C Starling, A F Hernandez, P W Armstrong, K Dickstein, V Hasselblad, G M Heizer, M Komajda, B M Massie, J J V McMurray,[...]. N Engl J Med 2011
812
42

Novel bifunctional natriuretic peptides as potential therapeutics.
Deborah M Dickey, John C Burnett, Lincoln R Potter. J Biol Chem 2008
66
40



Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
36

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Lincoln R Potter, Andrea R Yoder, Darcy R Flora, Laura K Antos, Deborah M Dickey. Handb Exp Pharmacol 2009
305
34



CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart.
Fernando L Martin, S Jeson Sangaralingham, Brenda K Huntley, Paul M McKie, Tomoko Ichiki, Horng H Chen, Josef Korinek, Gerald E Harders, John C Burnett. PLoS One 2012
42
38

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
930
29

A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
27

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
S Suga, K Nakao, K Hosoda, M Mukoyama, Y Ogawa, G Shirakami, H Arai, Y Saito, Y Kambayashi, K Inouye. Endocrinology 1992
651
25

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Takeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, Takeshi Tokudome, Takeshi Horio, Kenji Mori, Kenji Kangawa. J Am Coll Cardiol 2005
129
25

The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide.
S Jeson Sangaralingham, Brenda K Huntley, Fernando L Martin, Paul M McKie, Diego Bellavia, Tomoko Ichiki, Gerald E Harders, Horng H Chen, John C Burnett. Hypertension 2011
70
23

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.
Marica Bordicchia, Dianxin Liu, Ez-Zoubir Amri, Gerard Ailhaud, Paolo Dessì-Fulgheri, Chaoying Zhang, Nobuyuki Takahashi, Riccardo Sarzani, Sheila Collins. J Clin Invest 2012
548
23

Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
Takeshi Horio, Takeshi Tokudome, Toshiyuki Maki, Fumiki Yoshihara, Shin-Ichi Suga, Toshio Nishikimi, Masayasu Kojima, Yuhei Kawano, Kenji Kangawa. Endocrinology 2003
132
23

Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide.
Horng H Chen, James F Glockner, John A Schirger, Alessandro Cataliotti, Margaret M Redfield, John C Burnett. J Am Coll Cardiol 2012
69
23

Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
Tomoko Ichiki, John A Schirger, Brenda K Huntley, Frank V Brozovich, Joseph J Maleszewski, Sharon M Sandberg, S Jeson Sangaralingham, Soon J Park, John C Burnett. J Mol Cell Cardiol 2014
37
29

Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).
K J Koller, D G Lowe, G L Bennett, N Minamino, K Kangawa, H Matsuo, D V Goeddel. Science 1991
709
21

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.
Christopher Newton-Cheh, Martin G Larson, Ramachandran S Vasan, Daniel Levy, Kenneth D Bloch, Aarti Surti, Candace Guiducci, Sekar Kathiresan, Emelia J Benjamin, Joachim Struck,[...]. Nat Genet 2009
297
21

Cardiac fibrosis in mice lacking brain natriuretic peptide.
N Tamura, Y Ogawa, H Chusho, K Nakamura, K Nakao, M Suda, M Kasahara, R Hashimoto, G Katsuura, M Mukoyama,[...]. Proc Natl Acad Sci U S A 2000
427
21

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
Sarah Mangiafico, Lisa C Costello-Boerrigter, Ingrid A Andersen, Alessandro Cataliotti, John C Burnett. Eur Heart J 2013
154
21


A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.
Valentina Cannone, Guido Boerrigter, Alessandro Cataliotti, Lisa C Costello-Boerrigter, Timothy M Olson, Paul M McKie, Denise M Heublein, Brian D Lahr, Kent R Bailey, Maurizio Averna,[...]. J Am Coll Cardiol 2011
69
19


Effects of synthetic atrial natriuretic factor on renal function and renin release.
J C Burnett, J P Granger, T J Opgenorth. Am J Physiol 1984
733
19

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
447
19

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
W S Colucci, U Elkayam, D P Horton, W T Abraham, R C Bourge, A D Johnson, L E Wagoner, M M Givertz, C S Liang, M Neibaur,[...]. N Engl J Med 2000
692
19


Bioactivity and metabolism of C-type natriuretic peptide in normal man.
P J Hunt, A M Richards, E A Espiner, M G Nicholls, T G Yandle. J Clin Endocrinol Metab 1994
141
19

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
19

Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
327
19

Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.
Thomas G von Lueder, S Jeson Sangaralingham, Bing H Wang, Andrew R Kompa, Dan Atar, John C Burnett, Henry Krum. Circ Heart Fail 2013
94
19

Natriuretic peptide drug leads from snake venom.
S Vink, A H Jin, K J Poth, G A Head, P F Alewood. Toxicon 2012
44
20

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.
A J Stingo, A L Clavell, D M Heublein, C M Wei, M R Pittelkow, J C Burnett. Am J Physiol 1992
235
17

A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.
Paul M McKie, Alessandro Cataliotti, Brenda K Huntley, Fernando L Martin, Timothy M Olson, John C Burnett. J Am Coll Cardiol 2009
36
22

Natriuretic peptide receptor-C signaling and regulation.
Madhu B Anand-Srivastava. Peptides 2005
175
17

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
305
17

Natriuretic peptides: a new lipolytic pathway in human adipocytes.
C Sengenès, M Berlan, I De Glisezinski, M Lafontan, J Galitzky. FASEB J 2000
324
17

Impact of obesity on plasma natriuretic peptide levels.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Peter W F Wilson, Ramachandran S Vasan. Circulation 2004
676
17


Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
Jonathan D Sackner-Bernstein, Hal A Skopicki, Keith D Aaronson. Circulation 2005
543
17

Physiological role of silent receptors of atrial natriuretic factor.
T Maack, M Suzuki, F A Almeida, D Nussenzveig, R M Scarborough, G A McEnroe, J A Lewicki. Science 1987
17



Furin-mediated processing of Pro-C-type natriuretic peptide.
Chengliang Wu, Faye Wu, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2003
139
17

Human B-type natriuretic peptide is not degraded by meprin A.
Deborah M Dickey, Lincoln R Potter. Biochem Pharmacol 2010
23
30

A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation.
Deborah M Dickey, Andrea R Yoder, Lincoln R Potter. J Biol Chem 2009
39
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.